Cargando…
Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States
OBJECTIVE: National estimates of atherosclerotic cardiovascular disease (ASCVD) in the United States (US) are scarce, especially for patients grouped by cardiovascular risk, lipid-lowering therapy use, and low-density lipoprotein cholesterol (LDL-C) levels. The objective of this study was to estimat...
Autores principales: | Klimchak, Alexa C., Patel, Miraj Y., Iorga, Şerban R., Kulkarni, Natasha, Wong, Nathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315384/ https://www.ncbi.nlm.nih.gov/pubmed/34327452 http://dx.doi.org/10.1016/j.ajpc.2020.100010 |
Ejemplares similares
-
Lipid treatment status and goal attainment among patients with atherosclerotic cardiovascular disease in the United States: A 2019 update()
por: Gu, Jing, et al.
Publicado: (2022) -
Lipid-Lowering Treatment and the Lipid Goals Attainment in Patients with a Very High Cardiovascular Risk
por: Lis, Anna, et al.
Publicado: (2023) -
Reduced Specificity of Personal Goals and Explanations for Goal Attainment in Major Depression
por: Dickson, Joanne M., et al.
Publicado: (2013) -
Current Perspectives on the Attainment of Lipid Modification Goals Relating to the Use of Statins and Ezetimibe for the Prevention of Cardiovascular Disease in the United Kingdom
por: Reynolds, Timothy Mark, et al.
Publicado: (2021) -
Lipid-Lowering Efficacy of Ezetimibe in Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analyses
por: Shaya, Fadia Tohme, et al.
Publicado: (2019)